{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:47:37Z","timestamp":1769194057150,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T00:00:00Z","timestamp":1337817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00404-012-2349-8","type":"journal-article","created":{"date-parts":[[2012,6,20]],"date-time":"2012-06-20T14:57:48Z","timestamp":1340204268000},"page":"923-929","source":"Crossref","is-referenced-by-count":19,"title":["Botox\u00ae for idiopathic overactive bladder: efficacy, duration and safety. Effectiveness of subsequent injection"],"prefix":"10.1007","volume":"286","author":[{"given":"Roberta","family":"Granese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Adile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Gugliotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaspare","family":"Cucinella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Saitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biagio","family":"Adile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,24]]},"reference":[{"key":"2349_CR1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/clinids\/1.4.701","volume":"1","author":"E Ermengem van","year":"1979","unstructured":"van Ermengem E (1979) Classics in infectious diseases: a new anaerobic bacillus and its relation to botulism. Rev Infect Dis 1:701\u2013719","journal-title":"Rev Infect Dis"},{"key":"2349_CR2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1464-410X.2009.08402.x","volume":"103","author":"A Sahai","year":"2009","unstructured":"Sahai A, Dowson C, Khan MS et al (2009) Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial. BJU Int 103:1509\u20131515","journal-title":"BJU Int"},{"key":"2349_CR3","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1097\/00002508-200211001-00011","volume":"18","author":"CF O\u2019Brien","year":"2002","unstructured":"O\u2019Brien CF (2002) Treatment of spasticity with botulinum toxin. Clin J Pain 18:S182\u2013S190 (Review)","journal-title":"Clin J Pain"},{"key":"2349_CR4","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00120-007-1507-2","volume":"46","author":"M St\u00f6hrer","year":"2007","unstructured":"St\u00f6hrer M, Wolff A, Kramer G et al (2007) Seven years of botulinum toxin type A in the treatment of neurogenic detrusor hyperactivity. Urologe A 46:1211\u20131218","journal-title":"Urologe A"},{"key":"2349_CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1464-410X.2008.07827.x","volume":"1","author":"DM Schmid","year":"2008","unstructured":"Schmid DM, Roy S, Sulser T (2008) Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity. BJU Int 1:7\u201310","journal-title":"BJU Int"},{"key":"2349_CR6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","volume":"49","author":"A Apostolidis","year":"2006","unstructured":"Apostolidis A, Dasgupta P, Fowler CJ (2006) Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49:644\u2013650 (Review)","journal-title":"Eur Urol"},{"key":"2349_CR7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/0970-1591.40612","volume":"24","author":"NK Mohanty","year":"2008","unstructured":"Mohanty NK, Nayak RL, Alam M (2008) Role of botulinum toxin-A in management of refractory idiopathic detrusor overactive bladder: single center experience. Indian J Urol 24:182\u2013185","journal-title":"Indian J Urol"},{"key":"2349_CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.urology.2004.08.063","volume":"64","author":"WC Groat de","year":"2004","unstructured":"de Groat WC (2004) The urothelium in overactive bladder: passive bystander or active participant? Urology 64:7\u201311 (Review)","journal-title":"Urology"},{"key":"2349_CR9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1113\/jphysiol.2004.071159","volume":"562","author":"B Chopra","year":"2005","unstructured":"Chopra B, Barrick SR, Meyers S et al (2005) Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium. J Physiol 562:859\u2013871","journal-title":"J Physiol"},{"key":"2349_CR10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.annrmp.2008.03.003","volume":"51","author":"M S\u00e8ze De","year":"2008","unstructured":"De S\u00e8ze M, Ruffion A, Haab F et al (2008) Patient follow-up after botulinum toxin intradetrusor injection: proposal for management in neurogenic patients. Ann Readapt Med Phys 51:315\u2013321","journal-title":"Ann Readapt Med Phys"},{"key":"2349_CR11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M et al (2002) Standardisation Sub-committee of the International Continence Society: the standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167\u2013178","journal-title":"Neurourol Urodyn"},{"key":"2349_CR12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0090-4295(99)80384-7","volume":"147","author":"TH Wagner","year":"1996","unstructured":"Wagner TH, Patrick DL, Bavendam TG, Martin ML, Buesching DP (1996) Quality of life of persons with urinary incontinence: development of a new measure. Urology 147:67\u201371 (Discussion 71\u201372)","journal-title":"Urology"},{"key":"2349_CR13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpurol.2009.01.005","volume":"5","author":"X Gam\u00e9","year":"2009","unstructured":"Gam\u00e9 X, Mouracade P, Chartier-Kastler E et al (2009) Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review. J Pediatr Urol 5:156\u2013164","journal-title":"J Pediatr Urol"},{"key":"2349_CR14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.juro.2008.03.028","volume":"180","author":"L Brubaker","year":"2008","unstructured":"Brubaker L, Richter HE, Visco A et al (2008) Pelvic floor disorders network: refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol 180:217\u2013222","journal-title":"J Urol"},{"key":"2349_CR15","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/AOG.0b013e3181a1f5ea","volume":"113","author":"TM Kessler","year":"2009","unstructured":"Kessler TM, Khan S, Panicker J, Roosen A, Elneil S, Fowler CJ (2009) Clean intermittent self-catheterization after botulinum neurotoxin type A injections: short-term effect on quality of life. Obstet Gynecol 113:1046\u20131051","journal-title":"Obstet Gynecol"},{"key":"2349_CR16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00120-008-1918-8","volume":"48","author":"U Mehnert","year":"2009","unstructured":"Mehnert U, Schurch B (2009) Botulinum toxin in nonneurogenic bladder dysfunction. Urologe A 48:233\u2013244","journal-title":"Urologe A"},{"key":"2349_CR17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.eururo.2008.02.037","volume":"53","author":"A Apostolidis","year":"2008","unstructured":"Apostolidis A, Jacques TS, Freeman A et al (2008) Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity. Eur Urol 53:1245\u20131253","journal-title":"Eur Urol"},{"key":"2349_CR18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.ju.0000132152.53532.5d","volume":"172","author":"A Giannantoni","year":"2004","unstructured":"Giannantoni A, Di Stasi SM, Stephen RL, Bini V, Costantini E, Porena M (2004) Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. J Urol 172:240\u2013243","journal-title":"J Urol"},{"key":"2349_CR19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.eururo.2009.09.023","volume":"57","author":"TM Kessler","year":"2010","unstructured":"Kessler TM, Khan S, Panicker JN et al (2010) In the human urothelium and suburothelium, intradetrusor botulinum neurotoxin type A does not induce apoptosis: preliminary results. Eur Urol 57:879\u2013883","journal-title":"Eur Urol"},{"key":"2349_CR20","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B, St\u00f6hrer M, Kramer G, Schmid DM, Gaul G, Hauri D (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692\u2013697","journal-title":"J Urol"},{"key":"2349_CR21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"A Reitz","year":"2004","unstructured":"Reitz A, St\u00f6hrer M, Kramer G et al (2004) European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45:510\u2013515","journal-title":"Eur Urol"},{"key":"2349_CR22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","volume":"47","author":"J Grosse","year":"2005","unstructured":"Grosse J, Kramer G, St\u00f6hrer M (2005) Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47:653\u2013659","journal-title":"Eur Urol"},{"key":"2349_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","volume":"176","author":"DM Schmid","year":"2006","unstructured":"Schmid DM, Sauermann P, Werner M et al (2006) Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176:177\u2013185","journal-title":"J Urol"},{"key":"2349_CR24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eururo.2007.12.029","volume":"54","author":"V Kalsi","year":"2008","unstructured":"Kalsi V, Apostolidis A, Gonzales G, Elneil S, Dasgupta P, Fowler CJ (2008) Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity. Eur Urol 54:181\u2013187","journal-title":"Eur Urol"},{"key":"2349_CR25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eururo.2005.12.012","volume":"49","author":"V Kalsi","year":"2006","unstructured":"Kalsi V, Apostolidis A, Popat R, Gonzales G, Fowler CJ, Dasgupta P (2006) Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes. Eur Urol 49:528\u2013535","journal-title":"Eur Urol"},{"key":"2349_CR26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","volume":"174","author":"B Schurch","year":"2005","unstructured":"Schurch B, de S\u00e8ze M, Denys P, Botox Detrusor Hyperreflexia Study Team et al (2005) Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174:196\u2013200","journal-title":"J Urol"},{"key":"2349_CR27","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.eururo.2007.04.026","volume":"52","author":"B Schurch","year":"2007","unstructured":"Schurch B, Denys P, Kozma CM, Reese PR, Slaton T, Barron RL (2007) Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence. Eur Urol 52:850\u2013858","journal-title":"Eur Urol"},{"key":"2349_CR28","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.juro.2008.08.030","volume":"180","author":"WM White","year":"2008","unstructured":"White WM, Pickens RB, Doggweiler R, Klein FA (2008) Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population. J Urol 180:2522\u20132526","journal-title":"J Urol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-012-2349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-012-2349-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-012-2349-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:56:33Z","timestamp":1559066193000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-012-2349-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,24]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["2349"],"URL":"https:\/\/doi.org\/10.1007\/s00404-012-2349-8","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,24]]}}}